Table 1. Real-World Practices of Drug Repositioning Business Model.

Corporation	Founded	Headquarter	Status	Pipeline
Axovant Gene	2014	New York	IPO	3 Ph1/2
PharmaKure	2013	Manchester	Seed Round Financing	1 Preclinical
Denovo Biopharma	2011	San Diego	Series B Financing	1 Ph3; 2 Ph2; 2 Ph1

^*Corporate status and pipeline data were updated on April 1, 2020.